Chest PNF on Pulmonary Function in Parkinson Disease
Efficacy of Chest PNF on Pulmonary Function in Patients With Parkinson's Diseases
1 other identifier
interventional
20
1 country
1
Brief Summary
Background: Parkinson disease (PD) is a progressive neurodegenerative disorder and characterized by tremor, rigidity and bradykinesia. Almost 84% of PD patient develops respiratory abnormalities and pointed as the most common cause of death. Airway obstruction, trunk muscle rigidity is the common cause of respiratory abnormalities. Purpose: The main purpose of the study will evaluate the efficacy of chest PNF on pulmonary function and chest wall mobility in PD. Methods: 20 participants will be recruited for study purpose and divide into two groups. Group= A will be the control group and participants will receive conventional treatment which includes deep breathing exercise and segmental breathing exercise, incentive spirometry etc for one week. Group= B participants will receive chest PNF exercise along with conventional treatment for a week. Pretreatment and post-treatment data will be recorded by the help of PFT (FVC, FEV1 \& FEV1/FVC) and chest wall expansion at axillary and xiphisternal level for data analysis. Data analysis will be done by paired t-test for within group and independent t-test will be used for the between-group variable. The level of significance will be set at 0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 27, 2019
CompletedFirst Posted
Study publicly available on registry
June 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2019
CompletedJune 6, 2019
June 1, 2019
1.4 years
May 27, 2019
June 5, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Pulmonary Function Test (PFT)
Pulmonary functions parameters FVC in litre, FEV1 in litre and ratio between FVC/FEV1 will be recorded with PFT
changes bwtween baseline to 1 week
Secondary Outcomes (1)
chest wall expansion by inch tape
changes bwtween baseline to 1 week
Study Arms (2)
chest PNF
EXPERIMENTALparticipants received conventional chest physiotherapy along with chest PNF technique 5 days for 1 week. Chest PNF technique includes oblique downward pressure at the sternum, diagonal pressure at lower rib cage at the supine line, caudal medial pressure at side lying, Caudal pressure at ribcage at prone lying, dorsal and caudal pressure at prone on the elbow.
Conventional
ACTIVE COMPARATORparticipants received conventional chest physiotherapy treatment, which includes Deep breathing exercise, Diaphragmatic breathing exercise, segmental breathing exercise and purse lip breathing and incentive spirometer
Interventions
Chest PNF technique includes oblique downward pressure at sternum, diagonal pressure at lower rib cage at supine line, caudal medial pressure at side lying, Caudal pressure at ribcage at prone lying, dorsal and caudal pressure at prone on elbow.
conventional chest physiotherapy treatment, which includes Deep breathing exercise, Diaphragmatic breathing exercise, segmental breathing exercise and purse lip breathing and incentive spirometer
Eligibility Criteria
You may qualify if:
- Grade 3 to grade 5 Parkinson patients according to Hoehn Yahar scale
- MMSE score \>23.
- Age 50-70 yrs.
- Both Male and Female.
You may not qualify if:
- Previous history of cardiac and pulmonary surgery.
- History of flail chest.
- Individual affected by neurological disorder other than PD.
- Uncooperative patients.
- Individual with the psychosomatic disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MMIPR
Ambāla, Haryana, 133207, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- clinical professor
Study Record Dates
First Submitted
May 27, 2019
First Posted
June 6, 2019
Study Start
January 1, 2018
Primary Completion
June 10, 2019
Study Completion
June 10, 2019
Last Updated
June 6, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share